Alumis Inc. (ALMS)
Nasdaq: ALMS · Pharmaceutical Preparations · South San Francisco, CA · filing with the SEC since 2021
Income statement, as filed
In thousands of US dollars (USD), as filed; per-share figures in US dollars; share counts. The fiscal year ends in December.| Fiscal year | FY 2025 | FY 2024 | FY 2023 |
|---|---|---|---|
| Period ending | Dec 31, 2025 | Dec 31, 2024 | Dec 31, 2023 |
| Report filed | Mar 19, 2026 | Mar 19, 2025 | · |
| Revenue | 24,050 | · | · |
| Research and development | 385,998 | 265,554 | 137,676 |
| General and administrative | 91,856 | 35,200 | 20,498 |
| Total operating expenses | 477,854 | 300,754 | 158,174 |
| Operating income | -453,804 | -300,754 | -158,174 |
| Other income (expense), net | -169 | -93 | -68 |
| Total non-operating income (expense) | 201,918 | 6,521 | 3,181 |
| Income before income taxes | -251,886 | -294,233 | · |
| Income tax expense | -8,561 | 0 | 0 |
| Net income including non-controlling interests | -243,325 | -294,233 | -154,993 |
| Net income | -243,325 | -294,233 | -154,993 |
| Earnings per share, basic | -2.86 | -10.38 | -72.08 |
| Earnings per share, diluted | -2.86 | -10.38 | -72.08 |
| Weighted average shares, basic | 85,029,624 | 28,341,866 | 2,150,186 |
| Weighted average shares, diluted | 85,029,624 | 28,341,866 | 2,150,186 |
As filed with the SEC, each figure from the newest report that carries it, and linked to it. Nothing here is computed.A dot is a line not tagged for that period. r restated by the company in a later report; b a share figure put on the newest basis or filed in the wrong unit. Hover a figure for its filing and note.
What each line is, and the XBRL concept behind it
Revenue what customers paid for what it sold
us-gaap:RevenueFromContractWithCustomerExcludingAssessedTaxResearch and development spent on inventing what it sells next
us-gaap:ResearchAndDevelopmentExpenseGeneral and administrative the cost of running the company itself
us-gaap:GeneralAndAdministrativeExpenseTotal operating expenses the running costs together
us-gaap:OperatingExpensesOperating income profit from running the business, before interest and tax
us-gaap:OperatingIncomeLossOther income (expense), net gains and costs outside the business
us-gaap:OtherNonoperatingIncomeExpenseTotal non-operating income (expense) everything outside the business, together
us-gaap:NonoperatingIncomeExpenseIncome before income taxes profit before tax
us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterestIncome tax expense tax charged on the period's profit
us-gaap:IncomeTaxExpenseBenefitNet income including non-controlling interests the whole group's profit, minority holders' share included
us-gaap:ProfitLossNet income the profit or loss that belongs to the company's shareholders
us-gaap:NetIncomeLossEarnings per share, basic net income per share outstanding
us-gaap:EarningsPerShareBasicEarnings per share, diluted net income per share, counting every share that could be issued
us-gaap:EarningsPerShareDilutedWeighted average shares, basic the average count of shares outstanding
us-gaap:WeightedAverageNumberOfSharesOutstandingBasicWeighted average shares, diluted the average count with every share that could be issued
us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding